logo
Sign in

DRTS Stock Price, Chart, Stats & News

Alpha Tau Medical Ltd.
Save
883.39M
Market cap
Current P/E
Forward P/E

DRTS chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
Operating margin
Pretax margin
Net margin
Effective tax rate
-0.32%
ROA
-40.00%
ROE
-57.29%
D/E
0.18x
Interest coverage ratio

DRTS valuation

P/E
P/S
P/B
7.62x
P/CF
-22.03x
P/FCF
-18.43x
P/OCF
-22.03x
PEG
-0.14x
EV multiple
-14.59x

About

Alpha Tau Medical Ltd. is a clinical-stage biotechnology company dedicated to the advancement and eventual commercialization of innovative cancer treatments. Their primary focus is on "Alpha DaRT" (Diffusing Alpha-Emitters Radiation Therapy), a novel approach designed to combat solid tumors. This therapeutic radiation technique is currently undergoing clinical evaluation for various solid malignancies, including skin, oral, pancreatic, and breast cancers, with development efforts primarily concentrated in Israel and the United States.

Similar securities

Based on sector and market capitalization

Report issue